Rofo 2020; 192(07): 678-685
DOI: 10.1055/a-1100-0016
Breast

Stratification of Breast Cancer Risk in Terms of the Influence of Age and Mammographic density

Article in several languages: English | deutsch
Stefanie Weigel
1   Institute of Clinical Radiology and Reference Center for Mammography Münster, University and University Hospital Münster, Germany
,
Walter Heindel
1   Institute of Clinical Radiology and Reference Center for Mammography Münster, University and University Hospital Münster, Germany
,
Caroline Dietz
2   Screening Unit, Leverkusen, Germany
,
Ulrike Meyer-Johann
3   Screening Unit, Bielefeld, Germany
,
Axel Graewingholt
4   Screening Unit, Paderborn, Germany
,
Hans Werner Hense
5   Institute of Epidemiology and Social Medicine, University of Münster, Germany
› Author Affiliations

Abstract

Purpose Analysis of the influence of the singular risk factors age and breast density on the 2-year incidence of breast cancer among participants in the German mammography screening program.

Materials and Methods The multicenter study includes 111 456 subsequent round digital mammographic screening examinations from four screening units with prospective visual categorization of breast density. Based on detection in screening and during the 2-year interval after negative screening participation (interval cancers), 2-year breast cancer incidences (2 YBCI) (‰) were calculated in the 5-year age groups (5 YAG) of the target group 50–69 years and in the BI-RADS density categories ACR 1–4. Multivariate statistical evaluations were carried out using logistic regression models.

Results With an increase in the 5 YAG, the 2 YBCI increased by 5.0 ‰, 6.7 ‰, 8.5 ‰ to 9.7 ‰, and was significantly different among 55–59, 60–64 and 65–69-year-old women compared to the youngest reference group 50–54 years (odds ratio (OR): 1.34; 1.68; and 1.93; p-value < 0.0001). With an increase in density categories 1–4, the 2 YBCI increased from 2.6 ‰, to 5.8 ‰, 9.6 ‰, and 9.7 ‰. The 2 YBCI differed significantly in breast density categories 2, 3, 4 from reference group 1 (OR: 2.17; 3.65; and 3.76; p-value < 0.0001). Only within the two main breast density groups 2 (frequency 44.3 %) and 3 (44.7 %), a significant increase in the 2 YBCI was observed across the 5 YAG (category 2: 3.7–8.9 ‰; category 3: 5.8–11.7 ‰; p-value < 0.001 each). The 2 YBCI was above the median of 7.5 ‰ in women with breast density category 2 and aged 65–69 years, as well as in women with breast density categories 3 and 4 aged 55–69 years. A 2 YBCI below the median was seen in women between 50–54 years regardless of breast density, as well as women in category 1 in all age groups.

Conclusion Within the main breast density categories 2 and 3 (almost 90 % of participants), incidences increase with age to double. A consistently low incidence is found regardless of breast density at a young screening age and in women with the lowest breast density.

Key Points:

  • The risk of breast cancer is modified by age in density categories.

  • Women aged 50–54 years have a low risk in all density categories.

  • Women in category ACR 1 of any age group have a low risk.

Citation Format

  • Weigel S, Heindel W, Dietz C et al. Stratifizierung des Brustkrebsrisikos hinsichtlich der Einflüsse von Alter und mammografischer Dichte. Fortschr Röntgenstr 2020; 192: 678 – 685



Publication History

Received: 10 March 2019

Accepted: 22 December 2019

Article published online:
27 February 2020

© Georg Thieme Verlag KG
Stuttgart · New York

 
  • References

  • 1 Robert Koch Institute (ed.) and the Association of Population-based Cancer Registries in Germany (ed.). Cancer in Germany 2011/2012. 10th edition. Berlin: 2015
  • 2 Broeders M, Moss S, Nystrom L. et al The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies. J Med Screen 2012; 19: 14-25
  • 3 Lauby-Secretan B, Scoccianti C, Loomis D. et al Breast cancer screening-Viewpoint of the IARC working group. N Engl J Med 2015; 373: 2353-2358
  • 4 Bick U. Intensified surveillance for early detection of breast cancer in high-risk patients. Breast Care 2015; 10: 13-20
  • 5 www.krebsinformationsdienst.de/tumorarten/brustkrebs/brustkrebsrisiken-uebersicht.php
  • 6 Boyd NF, Guo H, Martin LJ. et al Mammographic density and the risk and detection of breast cancer. N Engl J Med 2007; 356: 227-236
  • 7 Pinsky RW, Helvie MA. Mammographic breast density: effect on imaging and breast cancer risk. J Natl Compr Canc Netw 2010; 8: 1157-1164
  • 8 Weigel S, Heindel W, Heidrich J. et al Digital mammography screening: sensitivity of the programme dependent on breast density. Eur Radiol 2017; 27: 2744-2751
  • 9 Checka CM, Chun JE, Schnabel FR. et al The relationship of mammographic density and age: implications for breast cancer screening. Am J Roentgenol 2012; 198: W292-W295
  • 10 Wengert GJ, Helbich TH, Kapetas P. et al Density and tailored breast cancer screening: practice and prediction – an overview. Acta Radiol Open 2018; 7 DOI: 2058460118791212.
  • 11 Anlage 9.2 BMV-Ä/EKV Bundesmantelvertrag Anlage 9.2. Versorgung im Rahmen des Programmes zur Früherkennung von Brustkrebs durch Mammografie-Screening. 2014 www.kbv.de/html/bundesmantelvertag.php
  • 12 American College of Radiology. Breast imaging reporting and data system: BI-RADS atlas. 4th edn. Reston: American College of Radiology; , VA 2003
  • 13 Lee CI, Chen LE, Elmore JG. Risk-based Breast Cancer Screening: Implications of Breast Density. Med Clin North Am 2017; 101: 725-741
  • 14 Cappello NM, Richetelli D, Lee CI. The Impact of Breast Density Reporting Laws on Women’s Awareness of Density-Associated Risks and Conversations Regarding Supplemental Screening With Providers. J Am Coll Radiol 2019; 16: 139-146
  • 15 Holland K, van Zelst J, den Heeten GJ. et al Consistency of breast density categories in serial screening mammograms: a comparison between automated and human assessment. Breast 2016; 29: 49-54
  • 16 Melnikow J, Fenton JJ, Whitlock EP. et al Supplemental Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the U.S. Preventive Service Task Force. [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US) 2016
  • 17 Sickles EA, D’Orsi CJ, Bassett LW. et al ACR BI-RADS® Mammography. In: ACR BI-RADS® Atlas, Breast Imaging Reporting and Data System. Reston: American College of Radiology; 2013
  • 18 Wanders JOP, van Gils CH, Karssemeijer N. et al The combined effect of mammographic texture and density on breast cancer risk: a cohort study. Breast Cancer Res 2018; 20: 36
  • 19 Bick U, Engel C, Krug B. et al High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for hereditary breast and ovarian cancer. Breast Cancer Res Treat 2019; 175: 217-228
  • 20 Bundesministerium für Umwelt. Naturschutz und nukleare Sicherheit Bekanntmachung der wissenschaftlichen Bewertung des Bundesamtes für Strahlenschutz gemäß § 84 Absatz 3 des Strahlenschutzgesetzes: Brustkrebsfrüherkennung mittels Mammographie vom 16. Dezember 2018. https://www.bundesanzeiger.de
  • 21 Weigel S, Heindel W, Heidrich J. et al Reduction of Advanced Breast Cancer Stages at Subsequent Participation in Mammography Screening. Fortschr Röntgenstr 2016; 188: 33-37
  • 22 Prange A, Bokhof B, Polzer P. et al Higher Detection Rates of Biologically Aggressive Breast Cancers in Mammography Screening than in the Biennial Interval. Fortschr Röntgenstr 2019; 191: 130-136
  • 23 Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF). S3-Leitlinie Früherkennung, Diagnose, Therapie und Nachsorge des Mammakarzinoms. Version 4.0, 2017 AWMF Registernummer: 032–045OL, http://www.leitlinienprogramm-onkologie.de/leitlinien/mammakarzinom/